Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies

被引:14
|
作者
Brnabic, Alan [1 ]
Lin, Chaucer [2 ,3 ]
Monkul, E. Serap [4 ]
Duenas, Hector [5 ]
Raskin, Joel [6 ]
机构
[1] OPTUMInsight, Lilyfield, NSW 2040, Australia
[2] Eli Lilly Taiwan, Taipei, Taiwan
[3] Buddhist Tzu Chi Gen Hosp & Univ, Hualien, Taiwan
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly Mexico, Mexico City, DF, Mexico
[6] Eli Lilly & Co, Toronto, ON, Canada
关键词
Major depressive disorder; Observational study; Painful physical symptoms; Pooled analysis; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; SYMPTOMATOLOGY IDS; SOMATIC SYMPTOMS; REMISSION; PREVALENCE; OUTCOMES; ASSOCIATION; RELIABILITY; DULOXETINE;
D O I
10.1185/03007995.2012.748654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This retrospective post-hoc analysis of observational studies assesses the frequency of painful physical symptoms (PPS) in patients with major depressive disorder (MDD) of varied severity as may be seen in clinical practice. Methods: Observational studies of MDD that collected a clinician-reported measure of depression severity and included assessment of PPS were screened for this individual patient-level analysis. Six observational studies were included that enrolled outpatients with a diagnosis of MDD (assessed using the 17-item Hamilton depression scale, Hospital Anxiety and Depression Scale-Depression, or Inventory of Depressive Symptomatology). Measures of PPS were based on the original study assessment (modified Somatic Symptom Inventory [SSI] and Visual Analogue Scale [VAS]). Patients were divided into analysis cohorts based on the presence or absence of PPS. To model PPS status, odds ratios were calculated from logistic regression for cross-sectional analysis (main analysis) and generalized linear mixed models for longitudinal models (exploratory longitudinal analysis). Results: For the main analysis, four studies (N = 2943, 71.6% female, mean age 45.3 years) were identified. Of 2901 eligible patients, 61.7% were classified as having painful physical symptoms (PPS+). At study entry, 73.1% (957/1309) of patients in the severe category of depression, 56.8% (537/945) of those with moderate depression, and 45.6% (295/647) of those with mild depression were PPS+. The exploratory longitudinal analysis was performed using a subset (N = 2430) from the studies used in the main analysis plus two others (an additional 7984 patients, 6742 of which were modeled). The likelihood of patients that were PPS- at baseline later developing PPS was 5% to 13% greater for patients with increased depression severity (P<0.001) and the likelihood of PPS+ patients later not having PPS was 9% to 17% less for patients with increased depression severity (P<0.0001). Conclusions: Since this is a retrospective aggregate analysis of several observational studies, and due to missing data, care should be taken in the interpretation of these results. Despite the use of adjustment techniques, selection bias and unmeasured confounding may still be an issue for comparative analysis as not all variables were collected for all studies. For patients treated in typical care settings, PPS were associated with depression severity. However, patients with mild and moderate depression also exhibited PPS. Clinicians should be aware that PPS are present, and may warrant treatment, across depression severities.
引用
收藏
页码:1891 / 1897
页数:7
相关论文
共 50 条
  • [21] Impact of painful physical symptoms on first-episode major depressive disorder in adults with subthreshold depressive symptoms: A prospective cohort study
    Li, Xiuwen
    Zhang, Huimin
    Wu, Keying
    Fan, Beifang
    Guo, Lan
    Liao, Yuhua
    McIntyre, Roger S.
    Wang, Wanxin
    Liu, Yifeng
    Shi, Jingman
    Chen, Yan
    Shen, Manjun
    Wang, Hongqiong
    Li, Lingjiang
    Han, Xue
    Lu, Ciyong
    GENERAL HOSPITAL PSYCHIATRY, 2024, 86 : 1 - 9
  • [22] Relationship between painful physical symptoms and severity of depressive symptomatology and suicidality
    Bahk, Won-Myong
    Park, Subin
    Jon, Duk-In
    Yoon, Bo-Hyun
    Min, Kyung Joon
    Hong, Jin Pyo
    PSYCHIATRY RESEARCH, 2011, 189 (03) : 357 - 361
  • [23] The efficacy of duloxetine (60 mg qd) in the treatment of painful physical symptoms in patients with major depressive disorder
    Wohlreich, MM
    Mallinckrodt, CH
    Lu, Y
    Detke, MJ
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2003, 55 (02) : 157 - 157
  • [24] Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder reply
    Kuga, Atsushi
    Tsuji, Toshinaga
    Hayashi, Shinji
    Matsubara, Mako
    Fujikoshi, Shinji
    Tokuoka, Hirofumi
    Yoshikawa, Aki
    Escobar, Rodrigo
    Tanaka, Kazuhide
    Azekawa, Takaharu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2507 - 2507
  • [25] Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder
    Yun, Yajun
    Zhang, Qi
    Zhao, Wenxuan
    Ma, Ting
    Fan, Hongzhen
    Bai, Luyuan
    Ma, Botao
    Qi, Siyuan
    Wang, Zhiren
    An, Huimei
    Yang, Fude
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2022, 163
  • [26] Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study
    Gaynor, Paula J.
    Gopal, Murali
    Zheng, Wei
    Martinez, James M.
    Robinson, Michael J.
    Hann, Danette
    Marangell, Lauren B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1859 - 1867
  • [27] Clinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetine
    Sheehan, David V.
    Chokka, Pratap R.
    Granger, Renee E.
    Walton, Richard J.
    Raskin, Joel
    Sagman, Doron
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (03) : 242 - 251
  • [28] Major depressive disorder in Latin America:: The relationship between depression severity, painful somatic symptoms, and quality of life
    Muñoz, RA
    McBride, ME
    Brnabic, AJM
    López, CJ
    Hetem, LAB
    Secin, R
    Dueñas, HJ
    JOURNAL OF AFFECTIVE DISORDERS, 2005, 86 (01) : 93 - 98
  • [29] Efficacy of adjunctive brexpiprazole on the core symptoms of major depressive disorder: A post hoc analysis of two pooled clinical studies
    Nelson, J. Craig
    Weiller, Emmanuelle
    Zhang, Peter
    Weiss, Catherine
    Hobart, Mary
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 227 : 103 - 108
  • [30] Efficacy of vortioxetine on the physical symptoms of major depressive disorder
    Christensen, Michael Cronquist
    Florea, Ioana
    Lindsten, Annika
    Baldwin, David S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (10) : 1086 - 1097